WO2007015270A3 - Nouvelles compositions a liberation controlee a base d'inhibiteurs selectifs de la recapture de la serotonine - Google Patents
Nouvelles compositions a liberation controlee a base d'inhibiteurs selectifs de la recapture de la serotonine Download PDFInfo
- Publication number
- WO2007015270A3 WO2007015270A3 PCT/IN2006/000274 IN2006000274W WO2007015270A3 WO 2007015270 A3 WO2007015270 A3 WO 2007015270A3 IN 2006000274 W IN2006000274 W IN 2006000274W WO 2007015270 A3 WO2007015270 A3 WO 2007015270A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- controlled release
- composition
- active
- serotonin reuptake
- released
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2006274565A AU2006274565B2 (en) | 2005-08-02 | 2006-08-01 | Novel controlled release compositions of selective serotonin reuptake inhibitors |
JP2008524679A JP5153629B2 (ja) | 2005-08-02 | 2006-08-01 | 選択的セロトニン再取り込み阻害剤の新規の制御放出組成物 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN696/KOL/2005 | 2005-08-02 | ||
IN696KO2005 | 2005-08-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007015270A2 WO2007015270A2 (fr) | 2007-02-08 |
WO2007015270A3 true WO2007015270A3 (fr) | 2007-04-19 |
Family
ID=37392535
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2006/000274 WO2007015270A2 (fr) | 2005-08-02 | 2006-08-01 | Nouvelles compositions a liberation controlee a base d'inhibiteurs selectifs de la recapture de la serotonine |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP5153629B2 (fr) |
AU (1) | AU2006274565B2 (fr) |
WO (1) | WO2007015270A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2008299921B2 (en) | 2007-09-13 | 2012-03-01 | Concert Pharmaceuticals, Inc. | Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof |
NZ598083A (en) * | 2009-08-24 | 2013-08-30 | Lundbeck & Co As H | New compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine |
US20140010883A1 (en) | 2011-03-17 | 2014-01-09 | Lupin Limited | Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor |
KR102441089B1 (ko) * | 2020-06-15 | 2022-09-07 | 환인제약 주식회사 | 의약 조성물 |
CN112494445A (zh) * | 2020-12-11 | 2021-03-16 | 丽珠集团丽珠制药厂 | 一种马来酸氟伏沙明组合物及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997003670A1 (fr) * | 1995-07-20 | 1997-02-06 | Smithkline Beecham P.L.C. | Compositions de paroxetine a liberation controlee |
WO1999000131A1 (fr) * | 1997-06-30 | 1999-01-07 | Endo Pharmaceuticals Inc. | Nouveau procede de fabrication de dispersions solides de paroxetine |
WO1999056751A1 (fr) * | 1998-05-07 | 1999-11-11 | Endo Pharmaceuticals Inc. | Procede de production en phase aqueuse de dispersions solides de paroxetine |
WO2002069969A1 (fr) * | 2001-03-02 | 2002-09-12 | A/S Gea Farmaceutisk Fabrik | Procede de preparation de comprimes pharmaceutiques contenant un hydrochlorure anhydre de paroxetine |
WO2004058229A1 (fr) * | 2002-12-24 | 2004-07-15 | Biovail Laboratories Inc. | Formulations d'inhibiteurs selectifs de recapture de la serotonine a liberation modifiee |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5910319A (en) * | 1997-05-29 | 1999-06-08 | Eli Lilly And Company | Fluoxetine enteric pellets and methods for their preparation and use |
ATE433318T1 (de) * | 1999-02-10 | 2009-06-15 | Pfizer Prod Inc | Osmotisches system zur verabreichung von wirkstoffen, die feste amorphe dispersionen enthalten |
WO2000071099A1 (fr) * | 1999-05-20 | 2000-11-30 | Elan Corporation, Plc | Preparations d'inhibiteurs specifiques du recaptage de la serotonine a liberation multiparticulaire regulee |
-
2006
- 2006-08-01 WO PCT/IN2006/000274 patent/WO2007015270A2/fr active Application Filing
- 2006-08-01 AU AU2006274565A patent/AU2006274565B2/en not_active Ceased
- 2006-08-01 JP JP2008524679A patent/JP5153629B2/ja not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997003670A1 (fr) * | 1995-07-20 | 1997-02-06 | Smithkline Beecham P.L.C. | Compositions de paroxetine a liberation controlee |
WO1999000131A1 (fr) * | 1997-06-30 | 1999-01-07 | Endo Pharmaceuticals Inc. | Nouveau procede de fabrication de dispersions solides de paroxetine |
WO1999056751A1 (fr) * | 1998-05-07 | 1999-11-11 | Endo Pharmaceuticals Inc. | Procede de production en phase aqueuse de dispersions solides de paroxetine |
WO2002069969A1 (fr) * | 2001-03-02 | 2002-09-12 | A/S Gea Farmaceutisk Fabrik | Procede de preparation de comprimes pharmaceutiques contenant un hydrochlorure anhydre de paroxetine |
WO2004058229A1 (fr) * | 2002-12-24 | 2004-07-15 | Biovail Laboratories Inc. | Formulations d'inhibiteurs selectifs de recapture de la serotonine a liberation modifiee |
Non-Patent Citations (1)
Title |
---|
DOUGHTY D G ET AL: "Dry Formulation Process Improves Stability of Paroxetine Tablets - Useful in the Treatment of Depression, Neuroses, Etc", STN WPIDS, 22 June 1995 (1995-06-22), XP002913188 * |
Also Published As
Publication number | Publication date |
---|---|
AU2006274565B2 (en) | 2012-05-17 |
JP5153629B2 (ja) | 2013-02-27 |
JP2009503057A (ja) | 2009-01-29 |
AU2006274565A1 (en) | 2007-02-08 |
WO2007015270A2 (fr) | 2007-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003072025A3 (fr) | Formulations a liberation modifiee d'au moins une forme de tramadol | |
WO2007000778A3 (fr) | Compositions pharmaceutiques a liberation modifiee et leurs procedes | |
WO2001078725A3 (fr) | Formulations a liberation modifiee contenant un agent hypnotique | |
WO2001085257A3 (fr) | Compositions d'antagoniste opioide et formes de dosage | |
RS52764B (en) | PRAMIPEXOL DOSAGE FOR USE ONLY ONE DAY | |
WO2004026256A3 (fr) | Preparations d'opioides a liberation soutenue et methodes d'utilisation | |
MY127797A (en) | 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol-containing pharmaceutical composition with slow release of active indgredient | |
Tuite et al. | Recent developments in the pharmacological treatment of Parkinson’s disease | |
EA200870368A1 (ru) | Антибиотические композиции с модифицированным высвобождением и способ их получения | |
WO2007010559A3 (fr) | Nouvelle composition de forme dosifiee pharmaceutique a liberation modifiee comprenant un inhibiteur de l'enzyme cyclooxygenase | |
WO2008084698A1 (fr) | Composition pharmaceutique à libération entretenue de tacrolimus | |
WO2007015270A3 (fr) | Nouvelles compositions a liberation controlee a base d'inhibiteurs selectifs de la recapture de la serotonine | |
TN2009000197A1 (en) | Sustained - release composition and method for producing the same | |
MX2012013135A (es) | Elaboracion de granulos sin activos y tabletas que comprenden los mismos. | |
CA2503361A1 (fr) | Compositions a liberation controlee | |
WO2006053089A3 (fr) | Methodes et formulations permettant de preparer des compositions pharmaceutiques contenant du bupropion | |
WO2003005967A3 (fr) | Formulation a liberation double comportant un ester ethylique de levodopa et un inhibiteur de decarboxylase dans une couche a liberation instantanee avec un ester ethylique de levodopa et un inhibiteur de decarboxylase dans un noyau a liberation controlee | |
CA2415154A1 (fr) | Preparations a liberation modifiee contenant des inhibiteurs selectifs de la recapture de la serotonine | |
DE60006362D1 (de) | Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen | |
CA2374039A1 (fr) | Preparations d'inhibiteurs specifiques du recaptage de la serotonine a liberation multiparticulaire regulee | |
IS6504A (is) | Ný galensk lyfjablanda með hægri losun á molsidómíni | |
ATE382332T1 (de) | Formulierung mit kontrollierter freisetzung enthaltend tamsulosin hydrochlorid | |
US20030229101A1 (en) | Tablets comprising ciprofloxacin hydrochloride | |
WO2002017877A3 (fr) | Compositions pour granules pharmaceutiques a liberation controlee destinees a limiter les effets secondaires de medicaments | |
TW200621314A (en) | Methods and formulations for making pharmaceutical compositions containing bupropion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2008524679 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006274565 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2006274565 Country of ref document: AU Date of ref document: 20060801 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2006274565 Country of ref document: AU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06780554 Country of ref document: EP Kind code of ref document: A2 |